The U.S. FDA has taken the following actions as of Aril 24 in its ongoing response effort to the COVID-19 pandemic: The FDA issued an immediately in effect guidance, Enforcement Policy for Remote Digital Pathology Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency, to help expand the availability of devices for remote reviewing and reporting of scanned digital images of pathology slides during this public health emergency.    The FDA issued a Drug Sa...